Nanotechnological drug delivery platforms represent a new paradigm for cancer
therapeutics as they improve the pharmacokinetic profile and distribution of …

Hydrogels are a versatile category of biomaterials that have been widely applied in the fields
of biomedicine for the last several decades. The three-dimensional polymeric crosslinked …

Non-melanoma skin cancer is one of the most common malignancies reported with high
number of morbidities, demanding an advanced treatment option with superior …

As a therapeutic tool inherited for thousands of years, traditional Chinese medicine (TCM)
exhibits superiority in tumor therapy. The antitumor active components of TCM not only have …

Skin cancer, such as melanoma and non-melanoma, is the most common malignancy in
white populations. The local therapy strategy plays an important role in skin cancer …

Breast cancer is the neoplasia of highest incidence in women worldwide. Docetaxel (DTX), a
taxoid used to treat breast cancer, is a BCS-class-IV compound (low oral bioavailability …

Nanostructured lipid carriers (NLC) have emerged as innovative drug delivery systems,
offering distinct advantages over other lipid-based carriers, such as liposomes and solid …

Nanostructured lipid carriers (NLCs) are a new generation of lipid vectors for drug delivery
systems (DDSs), which are composed of solid and liquid lipids dispersed throughout the …

Melanoma is one of the most threatening cancers due to its metastatic capacity and its
incidence is recently increasing due to ozone depletion and excessive exposure to …

The development of hydrophilic carriers for drug encapsulation represents a current
challenge. In this work lidocaine (LID) loaded with carboxymethyl chitosan (CCS) cross …